(Q36965847)

English

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues

scientific article published on November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

0 references

neuropsychology

1 reference

based on heuristic

inferred from title

Michael Perdices

2

object named as

Michael Perdices

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

author name string

Carissa M Coulston

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Christopher C Tennant

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Australian and New Zealand Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

869-884

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of smoking abstinence on visuospatial working memory function in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of nicotine on cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Nicotine effects on brain function and functional connectivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Nicotine reduces antisaccade errors in task impaired schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Nicotine-haloperidol interactions and cognitive performance in schizophrenics.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Nicotine improves delayed recognition in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Poor premorbid school performance is associated with later cigarette smoking among schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Smoking and cognitive deficits in schizophrenia: a pilot study.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Sensory-perceptual dysfunction in patients with schizophrenia and comorbid alcoholism

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Alcohol and drug use in schizophrenia as predictors of functional impairment

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cognitive disparity in schizophrenics with and without cocaine dependency

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Substance misuse and cognitive functioning in early psychosis: a 2 year follow-up.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

CANTAB explicit memory is less impaired in addicted schizophrenia patients.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Causal association between cannabis and psychosis: examination of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis use and the risk of later schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The cognitive neuropsychiatric approach to investigating the neurobiology of schizophrenia and other disorders.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Pharmacology and effects of cannabis: a brief review

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Gestalt perception in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The relationship between brain structure and neurocognition in schizophrenia: a selective review

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Are schizophrenic men at higher risk for developmental deficits than schizophrenic women? Implications for adult neuropsychological functions.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Pharmacokinetics and pharmacodynamics of cannabinoids

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of smoking marijuana on brain perfusion and cognition.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cognitive impairment in substance abuse

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neuropsychological performance in long-term cannabis users

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

D3 dopamine receptor, behavioral sensitization, and psychosis

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Self-reports by alcohol and drug abuse inpatients: factors affecting reliability and validity

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Does cognitive function improve with quetiapine in comparison to haloperidol?

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of pharmacological therapy on gait and cognitive function in depressed patients.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Long-term cognitive impact of anticholinergic medications in older adults.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neuropsychological correlates of positive vs. negative schizophrenic symptomatology.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Altered Behavioral Response to Dopamine D3 Receptor Agonists 7-OH-DPAT and PD 128907 Following Repetitive Amphetamine Administration

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Early-onset cannabis use and cognitive deficits: what is the nature of the association?

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

A review of the effects of nicotine on schizophrenia and antipsychotic medications

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of Cigarette Smoking on Psychopathology Scores in Patients With Schizophrenia: An Experimental Study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Nicotinic receptor desensitization and sensory gating deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Caffeine: The forgotten variable.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Chronic psychiatric patients' use of caffeine: pharmacological effects and mechanisms

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Caffeine and its effect on persons with mental disorders

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Caffeine and schizophrenia.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Caffeine consumption in hospitalized psychiatric patients.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Clozapine-induced electroencephalogram changes as a function of clozapine serum levels

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Seizures and schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Childhood head injury and expression of schizophrenia in multiply affected families

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Psychosis proneness and ADHD in young relatives of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Attention and information processing in schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

A simple (or simplistic?) cognitive model for schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Reduced binocular depth inversion in regular cannabis users

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cognitive functioning of long-term heavy cannabis users seeking treatment.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The cannabis withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The time course and significance of cannabis withdrawal

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Magnetic resonance spectroscopy and schizophrenia: what have we learnt?

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The functional neuroanatomy of brain cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

In vivo imaging of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Effects of marijuana on neurophysiological signals of working and episodic memory

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis use and psychosis.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Reducing the harms caused by cannabis use: the policy debate in Australia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabis induced dopamine release: an in-vivo SPECT study

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

A proposed pathological model in the hippocampus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1080%2F00048670701634952

21 January 2018

Identifiers

10.1080/00048670701634952

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36965847&oldid=2193538432"